DK147851C - Nonapeptidamidderivater til brug ved diagnosticering af hypofysefunktionog gonadotropindeficiens samt regulering af formeringen hos normale dyr - Google Patents

Nonapeptidamidderivater til brug ved diagnosticering af hypofysefunktionog gonadotropindeficiens samt regulering af formeringen hos normale dyr

Info

Publication number
DK147851C
DK147851C DK225073A DK225073A DK147851C DK 147851 C DK147851 C DK 147851C DK 225073 A DK225073 A DK 225073A DK 225073 A DK225073 A DK 225073A DK 147851 C DK147851 C DK 147851C
Authority
DK
Denmark
Prior art keywords
nonapeptidamide
hypophyphenic
diagnostication
gonadotropine
deficiency
Prior art date
Application number
DK225073A
Other languages
Danish (da)
English (en)
Other versions
DK147851B (da
Inventor
Mashiko Fujino
Shigeru Kobayashi
Mikihiko Obayashi
Susumu Shinagawa
Tsunehiko Fukuda
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP4268672A external-priority patent/JPS5324423B2/ja
Priority claimed from JP11845272A external-priority patent/JPS5324424B2/ja
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Priority to DK441083A priority Critical patent/DK149755C/da
Publication of DK147851B publication Critical patent/DK147851B/da
Application granted granted Critical
Publication of DK147851C publication Critical patent/DK147851C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/23Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/13Luteinizing hormone-releasing hormone; related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK225073A 1972-04-29 1973-04-25 Nonapeptidamidderivater til brug ved diagnosticering af hypofysefunktionog gonadotropindeficiens samt regulering af formeringen hos normale dyr DK147851C (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK441083A DK149755C (da) 1972-04-29 1983-09-27 Analogifremgangsmaade til fremstilling af lhrh-analoge nonapeptidamidderivater eller fysiologisk acceptable salte eller metalkomplekser deraf

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP4268672A JPS5324423B2 (fr) 1972-04-29 1972-04-29
JP4268672 1972-04-29
JP11845272A JPS5324424B2 (fr) 1972-11-24 1972-11-24
JP11845272 1972-11-24

Publications (2)

Publication Number Publication Date
DK147851B DK147851B (da) 1984-12-24
DK147851C true DK147851C (da) 1986-03-10

Family

ID=26382407

Family Applications (1)

Application Number Title Priority Date Filing Date
DK225073A DK147851C (da) 1972-04-29 1973-04-25 Nonapeptidamidderivater til brug ved diagnosticering af hypofysefunktionog gonadotropindeficiens samt regulering af formeringen hos normale dyr

Country Status (17)

Country Link
US (1) US3853837A (fr)
AT (1) AT333988B (fr)
AU (1) AU453931B2 (fr)
CA (1) CA1005815A (fr)
CH (1) CH580065A5 (fr)
CS (1) CS188162B2 (fr)
DE (2) DE2366379C2 (fr)
DK (1) DK147851C (fr)
ES (1) ES414197A1 (fr)
FI (1) FI56676C (fr)
FR (1) FR2183021B1 (fr)
GB (1) GB1403642A (fr)
HU (1) HU168696B (fr)
NL (2) NL176856C (fr)
NO (1) NO139560C (fr)
PL (1) PL95790B1 (fr)
SE (1) SE397520B (fr)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3931138A (en) * 1973-03-13 1976-01-06 Abbott Laboratories N-carbobenzoxy-pyroglutamyl-histidine
CS180644B2 (en) * 1973-09-29 1978-01-31 Takeda Chemical Industries Ltd Process for preparing nonapeptides
GB1532211A (en) * 1974-10-25 1978-11-15 Wellcome Found Lh-rh peptide analogues
US4338305A (en) * 1975-03-24 1982-07-06 American Home Products Corporation Use of LRH and LRH agonists
AU497512B2 (en) * 1975-04-15 1978-12-14 Ici Australia Limited Nona and deca-peptides
US4034082A (en) * 1976-03-01 1977-07-05 Abbott Laboratories Method to prevent reproduction in warm-blooded female animals with nonapeptides
DE2905502C2 (de) * 1979-02-14 1982-07-15 Hoechst Ag, 6000 Frankfurt Verfahren zur Herstellung von LH-RH bzw. LH-RH-Analoga und Pyroglutamyl-N↑i↑m↑-dinitrophenyl-histidin
DE3020941A1 (de) * 1980-06-03 1981-12-17 Hoechst Ag, 6000 Frankfurt Nonapeptid, verfahren zu seiner herstellung, dieses enthaltendes mittel und seine verwendung
US4675189A (en) * 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
US4659696A (en) * 1982-04-30 1987-04-21 Takeda Chemical Industries, Ltd. Pharmaceutical composition and its nasal or vaginal use
HU193607B (en) * 1985-07-18 1987-11-30 Innofinance Altalanos Innovaci Process for production of sexual products applyable for natural or artificial insemination for mammates
US4897268A (en) * 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
US5068221A (en) * 1989-05-09 1991-11-26 Mathias John R Treatment of motility disorders with a gnrh analog
JP2653255B2 (ja) 1990-02-13 1997-09-17 武田薬品工業株式会社 長期徐放型マイクロカプセル
CA2050425A1 (fr) 1990-09-03 1992-03-04 Yoshiaki Uda Composition pharmaceutique et son utilisation avec du mucus
ZA918168B (en) 1990-10-16 1993-04-14 Takeda Chemical Industries Ltd Prolonged release preparation and polymers thereof.
US5434136A (en) * 1990-12-14 1995-07-18 Mathias; John R. Treatment of motility disorders with a GNRH analog
US5518730A (en) * 1992-06-03 1996-05-21 Fuisz Technologies Ltd. Biodegradable controlled release flash flow melt-spun delivery system
EP0582459B1 (fr) 1992-08-07 1998-01-07 Takeda Chemical Industries, Ltd. Production de microcapsules de médicaments solubles dans l'eau
EP0668073B1 (fr) * 1994-02-21 1999-04-14 Takeda Chemical Industries, Ltd. Matrice en polyester pour une préparation pharmaceutique à libération prolongée
US6117455A (en) * 1994-09-30 2000-09-12 Takeda Chemical Industries, Ltd. Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent
US5837281A (en) 1995-03-17 1998-11-17 Takeda Chemical Industries, Ltd. Stabilized interface for iontophoresis
US6413536B1 (en) 1995-06-07 2002-07-02 Southern Biosystems, Inc. High viscosity liquid controlled delivery system and medical or surgical device
US7833543B2 (en) * 1995-06-07 2010-11-16 Durect Corporation High viscosity liquid controlled delivery system and medical or surgical device
CA2192773C (fr) 1995-12-15 2008-09-23 Hiroaki Okada Obtention d'une preparation a liberation prolongee pour injection
CA2192782C (fr) 1995-12-15 2008-10-14 Nobuyuki Takechi Production de microsphere
CA2208336A1 (fr) * 1996-06-20 1997-12-20 Hisamitsu Pharmaceuticals Co., Inc. Un systeme pour l'iontopherese
US6051558A (en) * 1997-05-28 2000-04-18 Southern Biosystems, Inc. Compositions suitable for controlled release of the hormone GnRH and its analogs
US20060025328A1 (en) * 1997-05-28 2006-02-02 Burns Patrick J Compositions suitable for controlled release of the hormone GnRH and its analogs
EP0882736A1 (fr) * 1997-06-02 1998-12-09 Laboratoire Theramex S.A. Analogues peptidiques du LH-RH, leurs utilisations et compositions pharmaceutiques les contenant
JP4414517B2 (ja) 1999-09-01 2010-02-10 久光製薬株式会社 イオントフォレーシス用デバイス構造体
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
SI2218448T1 (sl) 2002-12-13 2016-01-29 Durect Corporation Sistem za oralno dajanje zdravila, ki obsega tekoči nosilec materialov z visoko viskoznostjo
EA201001885A1 (ru) 2004-09-17 2011-12-30 Дьюрект Корпорейшн Система контролируемой доставки
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
PT2117521E (pt) 2006-11-03 2012-09-10 Durect Corp Sistemas de administração transdérmica que compreendem bupivacaína
AU2008335809A1 (en) 2007-12-06 2009-06-18 Durect Corporation Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition
US20100260844A1 (en) * 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
CN105120659A (zh) 2013-03-15 2015-12-02 度瑞公司 用于降低溶解可变性的具有流变改性剂的组合物
EP4090353A4 (fr) 2020-01-13 2023-08-09 Durect Corporation Systèmes d'administration de médicament à libération prolongée avec impuretés réduites et procédés associés

Also Published As

Publication number Publication date
FR2183021B1 (fr) 1976-04-09
DE2321174A1 (de) 1973-11-08
DK147851B (da) 1984-12-24
SE397520B (sv) 1977-11-07
NL930004I1 (nl) 1993-04-01
CA1005815A (en) 1977-02-22
NL176856C (nl) 1985-06-17
NO139560B (no) 1978-12-27
AU453931B2 (en) 1974-10-17
HU168696B (fr) 1976-06-28
GB1403642A (en) 1975-08-28
CH580065A5 (fr) 1976-09-30
CS188162B2 (en) 1979-02-28
AT333988B (de) 1976-12-27
FI56676C (fi) 1980-03-10
ATA377173A (de) 1976-04-15
FI56676B (fi) 1979-11-30
ES414197A1 (es) 1976-05-01
FR2183021A1 (fr) 1973-12-14
NO139560C (no) 1979-04-04
DE2366379C2 (de) 1985-01-17
US3853837A (en) 1974-12-10
DE2321174C2 (de) 1982-04-15
PL95790B1 (pl) 1977-11-30
NL7305995A (fr) 1973-10-31
AU5467673A (en) 1974-10-17

Similar Documents

Publication Publication Date Title
DK147851C (da) Nonapeptidamidderivater til brug ved diagnosticering af hypofysefunktionog gonadotropindeficiens samt regulering af formeringen hos normale dyr
DK20979A (da) 4-amino-5-alkylsulfonyl-0-anisamid-derivater samt fremgangsmaade til fremstilling deraf
DK293575A (da) Triazolyl-alkanoner og -alkanoler samt fremgangsmade til deres fremstilling og deres anvendelse
NL930029I1 (nl) Enzyme derivatives and their preparation
SE418088B (sv) Med glyoxal behandlad akrylpolymer i finfordelad form samt motsvarande framstellningsforfarande
DK222382A (da) Benzezepinderivater fremgangsmaade til deres fremstilling samt deres anvendelse
DK282880A (da) Aminoalkylbenzen-derivater samt fremgangsmaade til fremstilling deraf
DK301477A (da) Fremgangsmaade til stereoselektiv fremstilling af hexahydrodibenzopyranoner samt mellemprodukt til brug ved fremgangsmaaden
FI800091A (fi) Saett vid defibrering resp raffinering av lignocellulosahaltiga fibermaterial
MX150412A (es) Mejoras en taco expansible
DK291180A (da) Indolizinderivater samt fremgangsmaade til fremstilling deraf
SE7607107L (sv) Forfarande och anleggning for reglering av fetthalten i mjolk
NL7900572A (nl) Pigmentmengsels en werkwijze voor hun bereiding.
DK254780A (da) Alkoxybenzylpyridopyridiner fremgangsmaade til deres fremstilling samt deres anvendelse
AR221831A1 (es) Composicion conservadora de madera y de productos lenosos
NO149477C (no) Fremgangsmaate for fremstilling av limt papir samt limemiddel for bruk i fremgangsmaaten
CH532031A (de) Verfahren zur Herstellung von in 2-Stellung substituierten 5-Nitro-furan-, 5-Nitro-thiophen- und 5-Nitro-pyrrolderivaten
NL7900573A (nl) Pigmentmengsels en werkwijze voor hun bereiding.
CH484913A (de) Verfahren zur Herstellung von blutdrucksenkend und sedativ wirksamen Derivaten des 2-(2-Halogenanilino)-1,3-diazacyclopentens-(2)
IT971959B (it) Formulazione atta all impiego in isocianurati rigidi e relativi isocianurati rigidi
SE431411B (sv) Gjutningsmaskin samt anvendning av densamma
DK54179A (da) N-azolylalkyl-anillin samt fremgangsmaader til deres fremstilling
CH484912A (de) Verfahren zur Herstellung von blutdrucksenkend und sedativ wirksamen Derivaten des 2-Anilino-1,3-diazacyclopentens-(2)
DK345677A (da) Fremgangsmade til fremstilling af cyanoprostaglandiner samt mellemprodukt til brug ved fremgangsmaden
IL32216A0 (en) Derivatives of the 2-(lower alkyl)-3-(lower alkyl)-4-aryl-cyclohexenylcarbinols and their preparation

Legal Events

Date Code Title Description
PUP Patent expired